Non-Opioid Pain Therapy Discovered at Stony Brook Advances with $11 Million Private Investment
A novel, non-opioid pain drug candidate originating from research at the State University of New York at Stony Brook has reached a significant milestone, as Artelo Biosciences announced on March...Read More
